Page last updated: 2024-10-23

astemizole and Lung Adenocarcinoma

astemizole has been researched along with Lung Adenocarcinoma in 1 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chatziantoniou, A1
Zaravinos, A1

Other Studies

1 other study available for astemizole and Lung Adenocarcinoma

ArticleYear
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer.
    International journal of molecular sciences, 2022, Sep-18, Volume: 23, Issue:18

    Topics: Adenocarcinoma of Lung; Astemizole; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms;

2022